Publication | Closed Access
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis
84
Citations
22
References
2001
Year
Results suggest that DRB1*1501 might be relevant for the clinical outcome in Cop-1 treated patients and, if confirmed in larger studies, it could be helpful in the selection of RRMS patients for different therapeutic options.
| Year | Citations | |
|---|---|---|
Page 1
Page 1